IMU 2.08% 4.9¢ imugene limited

Fair enough, looks like you're right about that being the...

  1. 43 Posts.
    lightbulb Created with Sketch. 25
    Fair enough, looks like you're right about that being the patient being the longest on that chart.

    Might be splitting hairs here but i think based on the naming convention it's actually the 2nd patient "US02-001" i'd suggest means site 2 patient 1. So they came after site 1 patient 1 who may have withdrawn from the study and so is not reflected in the chart as being on the study for as long.

    I still stand by my other paragraph
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.